Skip to main content

GRAIL Inc

For the period ended Dec 31, 2024. Filed Mar 5, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 5, 2025

GRAL$128.08+5.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Operations

(Amounts in thousands, except per share data)

Year Ended
December 31,2024December 31,2023January 1,2023
Revenue:
Screening revenue(1)$108,627$74,999$39,817
Development services revenue16,96818,10615,733
Total revenue125,59593,10555,550
Costs and operating expenses:
Cost of screening revenue (exclusive of amortization of intangible assets)(2)63,28447,96632,140
Cost of development services revenue(3)6,4446,8615,968
Cost of revenue — amortization of intangible assets133,889133,889133,889
Research and development(4)322,380338,745329,576
Sales and marketing153,958162,292122,328
General and administrative(5)213,862200,268174,108
Goodwill and intangible assets impairment1,420,936718,4664,700,431
Total costs and operating expenses2,314,7531,608,4875,498,440
Loss from operations(2,189,158)(1,515,382)(5,442,890)
Other income:
Interest income26,7337,9541,740
Other income (expense), net64(208)(238)
Total other income, net26,7977,7461,502
Loss before income taxes(2,162,361)(1,507,636)(5,441,388)
Benefit from income taxes135,35641,95142,290
Net loss$(2,027,005)$(1,465,685)$(5,399,098)
Net loss per share — Basic and Diluted$(63.54)$(47.21)$(173.89)
Weighted-average shares of common stock used in computing net loss per share:31,901,25931,049,14831,049,148

(1) Includes related party screening revenue of $460, $652 and $694, respectively.

(2) Includes related party cost of screening revenue of $13,091, $8,532 and $4,142, respectively.

(3) Includes related party cost of development services revenue of $637, $238 and $227, respectively.

(4) Includes related party research and development expenses of $18,843, $19,508 and $18,780, respectively.

(5) Includes related party general and administrative expenses of $104, $206 and $614, respectively.

See accompanying notes to consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.